Breath Analyzers Market will Grow at a CAGR of 41.3% from 2013 to 2019

Breath Aanalyzers Market

Breath Analyzers Market was valued at USD 402.1 million in 2012 and is estimated to reach a market worth USD 4,518.4 million in 2019 at a CAGR of 41.3% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/breath-analyzer-market.html

A rise in the trend for excessive alcohol consumption coupled with a rise in the number of road accidents has led to an increase in the usage of breath testing devices. Moreover, augmented demand from the healthcare sector for disease diagnosis along with strong government support are some of the factors responsible for boosting the uptake of breath analyzers, resulting in the overall growth of the breath analyzers market. Breath analyzers are the devices used for estimating blood alcohol content through an exhaled breath. Breath analysis is considered an indispensable tool for the screening of alcohol, drugs, asthma, tuberculosis and other diseases. These devices are gaining importance owing to their non-invasive nature, reliable and accurate result delivery over blood or urine test.

In the U.S. nearly half of road accidents are estimated to occur due to excessive alcohol consumption and drug abuse. Similarly, the number of deaths soared by 26% in Britain due to drunk driving in 2012. Thus, alcohol enforcements remain a priority for governments across the globe. Governments of various countries are strictly enforcing safety laws and are heavily emphasizing on work safety issues. Moreover, they are compelling organizations, vehicle owners and others to install portable breath analyzers at their work places.

In the global breath analysis market, the fuel cell technology segment accounted for the largest share and is anticipated to lead the market during the forecast period. The growth in this segment is attributed to technology efficiency, accuracy and the increasing popularity of breath testing devices. The alcohol testing segment accounted for the largest share of the market owing to the rising trend of road accidents and other causalities due to excessive alcohol consumption. The tuberculosis detection market is anticipated to show highest growth of 44.7% from 2013 to 2019. The growth in this segment is attributed to increasing incidence of tuberculosis especially in developing countries and increasing demand for a non-invasive surgery and accurate screening tool.

Geographically, North America accounts for the largest share of the breath analyzers market followed by Europe. The growth in this region is attributed to multiple factors such as rising awareness, increased government initiatives and a growing need for alcohol testing devices to curb risk of casualties arising out of excessive alcohol consumption. Moreover, dominance in this region is also witnessed due to increasing focus on development of breath testing devices for medical diagnosis. Despite the developed countries holding the major share, the Asia-Pacific region is likely to emerge as the fastest growing market during the analysis period. The market in this region would be influenced by the growing number of vehicle users and rise in disposable incomes that has recently reported a sudden rise in number of accidents due to excessive alcohol consumption, thereby increasing the demand for breath testing devices, consequently accelerating the growth of this market.

Browser full report Pdf with TOC : Breath Analyzers Market

Key players of this market include Alcohol Countermeasure Systems Inc., Dragerwerk AG & Co, Ekips Technologies, Inc., MPD, Inc., Intoximeters, Inc., Lifeloc Technologies, Inc., among other significant players.

The breath analyzers market is segmented as follows:

  • Breath Analyzers Market, by Technology
  • Fuel Cell
  • Semiconductor Sensor
  • Infrared Absorption
  • Breath Analyzers Market, by Application
  • Alcohol Detection
  • Drug Abuse Detection
  • Asthma Detection
  • Tuberculosis Detection
  • H.pylori Infection Detection
  • Others
  • Breath Analyzers Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • RoW

Browse all Energy Market Research Reports @ http://www.transparencymarketresearch.com/energy-market-reports-3.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog: TMR Market Reports

Prefilled Syringes Market Will Reach USD 4.98 Billion By 2019 : Transparency Market Research

Prefilled Syringes Market Will Reach USD 4.98 Billion By 2019 : Transparency Market Research

Prefilled Syringes Market (Glass and Plastic) – Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 – 2019

Prefilled Syringes Market

 The global prefilled syringes market was valued at USD 2.09billion in 2012 and is expected to grow at a CAGR of 13.3% from 2013 to 2019, to reach an estimated value of USD 4.98billion in 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/prefilled-syringes-market.html

Prefilled syringes are advanced drug delivery devices filled with single measured dose of high-end injectable drugs. Thesesyringes are gradually becoming the most preferred delivery devices for various categories of injectable drugs, mainly due to the advantages offered to drug manufacturers, healthcare providers and patients over conventional vial and ampoule packaging systems. To drug manufacturers, they are important because they reduce overfill to 4%-5% from 20% in vials, and thus, are preferred for dispensing therapeutic classes (mainly biologics) which are expensive. With respect to healthcare providers and patients, prefilled syringes help with factors such as ease of operation, low risk of contamination and accurate dosing.

Glass has been the most preferred material over decades for syringe manufacturing, owing to its properties such as non-reactive nature, robustness, transparency and tolerability against heat. Consequently, glass based prefilled syringes accounted for the larger share(more than 90%) of the total market in 2012, both by revenue as well as volume.Sincethe past few years, the industry is witnessing a shift towards the usage of plastic in place of glass in response to some significant disadvantages associated with glass, such as high risk of breakability and increased level of leachability from silicone layer in the presence of biologics. Under the influence of continued development in the area of polymer technology, the market for plastic based syringes is expected to grow at a CAGR more than double of that of glass syringes duringthe forecast period from 2013 to 2019. Nevertheless, glass syringes will still dominate the total global market for prefilled syringes in 2019, in terms of percent share by revenue as well as volume.

Browse the full report PDF with TOC :Prefilled Syringes Market (Glass and Plastic) – Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 – 2019

Boost in the use of biologics and other potent injectable drugs, technical advances in prefilled syringe manufacturing and packaging, rising demand for self-administration and increasing elderly population suffering from various chronic diseases that require frequent parenteral dosing are some major drivers anticipated totrigger market growth during the forecast period. On the other hand, burgeoning concerns regarding needlestick safety and prevention, rising manufacturing costs and issues with drug stability are some of the challenges likely to affect the growth of the global prefilled syringes market.

Geographically, Europe constituted the largest market share for prefilled syringes in 2012, owing to the high adoption rate of these delivery devices in the region. However, the North American market is predicted to grow at a higher CAGR (15%) than Europe during the forecast period to reach a value similar to that of the European market. Major drivers expected to contribute to this market growth include increasing awareness regarding benefits of prefilled syringes and presence of a large number of biopharmaceuticals under clinical development targeted for parenteral administration. In addition, the high growth economies of emerging nations such as India, China, Brazil, Russia and Mexico are attracting manufacturers to invest in these lucrative markets. Japan is a well-established market for prefilled syringes among Asian countries.

The market for prefilled syringes is oligopolistic in nature and is dominated by a few key players, namely, Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG and Stevanato Group. Other vendors operating in the market include Unilife Corporation, West Pharmaceutical Services, Inc., Baxter International, Inc. and Ypsomed Holding AG.

The global prefilled syringes market is segmented as follows:

Prefilled Syringes Market, by Segment

  • Glass Prefilled Syringes Market
    • By Revenue (USD Million)
    • By Volume (Million units)
    • Plastic Prefilled Syringes Market
    • By Revenue (USD Million)
    • By Volume (Million units)

Prefilled Syringes Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Visit Here Also : https://tmrreports.wordpress.com/

 

 

Research And Industry Analysis Of Orthobiologics Market From 2013 to 2019

Research And Industry Analysis Of Orthobiologics Market From 2013 to 2019

Orthobiologics Market

Orthobiologics Market was valued at USD 3,754.6 million in 2012 and is estimated to reach a market worth USD 5,519.9million in 2019at a CAGR of 5.9% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/orthobiologics-market.html

Orthobiologics are biomaterials used by surgeons for faster healing and quick recovery of injured muscles, bones, ligaments and tendons. It is estimated that bone and joint disorders account for approximately half of the devastating conditions in individuals with above 50 years of age. Moreover, population aged 60 years and above is expected to double by 2020 that alone represents the key driver of this market.A rise in geriatric population, lifestyle changes coupled with growing awareness of sports and outdoor activities among the older as well as younger generation has triggered the growth of this market. Moreover, rise in obese population has concurrently led to rise in prevalence of disorders such as osteoarthritis, rheumatoid arthritis and others. In addition, technological advancements and growing adoption of bone graft substitutes are the other factors that are fuelling the growth of this market.

Viscosupplements represents the largest product segments in the orthobiologics market. Demand for viscosupplements is increasing with the rise in an aging population that is more susceptible to osteoarthritic conditions. Moreover, the benefits of viscosupplements over (Non-Steroidal Anti Inflammatory Drugs) NSAIDs and other pain relieving treatments have further boosted the growth of this market. Stem cell-based products are expected to show highest growth rate in the near future. Reduced costs, faster healing, quick recovery and ability to mimic autologous bone are some of the major factors anticipated to propel the growth of this market. BMP (Bone Morphogenic Proteins) which is one of the largest revenue contributors of orthobiologics in the past is expected to show a negative growth during the forecast period. Recall of INFUSE (Medtronic, Inc.) by the FDA due to heavy off label usage, which is reported to have serious side effects have created negative impact on its sales. This has hampered the overall BMP market growth. Usage of synthetic bone substitutes is predicted to increase in coming years of forecast, primarily due to a host of factors such as cost effectiveness, improved outcomes and reduction in risk of disease transmission.

Browse the full report PDF with TOC : Orthobiologics Market 2013 – 2019

Spinal fusion accounted for the largest share of the market due to increase in number of spinal fusion surgeries. According to the American Academy of Orthopedic Surgeons (AAOS), approximately 465,000 spinal surgeries were performed in the U.S in 2011 and this trend is expected to grow in the future owing to rise in geriatric population. The reconstructive surgery market is poised to have the highest growth from 2013-2019. The growth in this market is attributed to increase in hip and knee replacement surgeries. Moreover, growing awareness about the impact of joint problems and rise in sports related activities is further propelling the growth of this market.

Geographically, North America accounted for the largest share of orthobiologics market in 2012 valued at more than USD 1.5billion in 2012 followed by Europe. However, Asia-Pacific region is expected to represent the highest CAGR of over 6.4% during the forecast period owing to growing awareness about the orthopedic treatment, rising disposable income and rise in incidence of chronic arthritis.

The orthobiologics market is becoming highly lucrative for manufacturers owing to the significant growth opportunities in this field. Moreover, players are seeking to develop alternatives to the standard autograft bone due to risk of infection transmission, limited supply and to avoid lengthy hospital stay. Major players of this market include Medtronic Inc., Stryker Corporation, Sanofi, DePuySynthes, Inc., Globus Medical, Inc., Integra LifeSciences Corporation and others.

The orthobiologics market is segmented as follows:

Orthobiologics Market, by Products

  • Allografts
  • Machined Bones
  • Demineralized Bone Matrix (DBM)
  • Bone Morphogenic Protein (BMP)
  • Viscosupplementation
  • Stem cell therapy

Orthobiologics Market, by Application

  • Spinal Fusion
  • Trauma
  • Reconstructive Surgeries

Orthobiologics Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/

The Global Growth Factors of the Organ Preservation Solutions Market

The Global Growth Factors of the Organ Preservation Solutions Market

The organ preservation solutions market has been playing an important role in increasing the number of organ transplants. Basically, an organ preservation solution is a method that helps in preserving organs in a special place when they are no longer inside a human body. The preservation solutions make the organs vulnerable to the exterior environment present outside the human body. The organs that are removed from the human body are then preserved in specific preservative solutions for multifarious purposes such as development of drugs and biologics and organ transplant procedures and research and development.

Organ Preservation Solutions Market1

Now-a-days, organ preservation solutions is widely utilized for preserving different organs such as liver and kidney because it is highly capable of preserving a variety of organs unlike the solutions HBS and Perfadexs.

Browse the full report PDF with TOC : Organ Preservation Solutions Market predicted to reach USD 204.9 Million Globally in the Forecast 2013 – 2019

Major Categories in Organ Preservation Solutions

According to the global market data, the organ preservation solutions has been sectioned into nine major solutions including Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor).

Various Organ Preservation Techniques

Many interesting medical techniques are acquired and implemented to preserve the organs in appropriate spaces. On the basis of organ preservation techniques, the market has been segmented into three categories namely hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques). However, unlike the static cold storage (SCS) technique which does not allow any type of continuous contact of the organ with the solution, the hypothermic perfusion preservation (HPP) technique is a much viable technique to adapt. It is a machine perfusion process that maintains a continuous supply to the organs required by the solution. This helps the organs to survive properly in the duration.

Value-Drive Growth Factors of the Organ Preservation Solutions Market

Considering the diseases and disorders spread amongst a variety of people across the world, rising incidences of organ failures in the patients has stirred the maximum demand for organ preservation solutions market. The organ preservation solutions market is primarily driven by organ failures that in turn necessitate organ transplant procedures. Worldwide, there are a number of patients that are highly eager to get an organ transplant done so that they live a smooth and stress-free life. Another factor that has stimulated the demand for the organ preservation solutions market is people’s lifestyle. Today, people are more addicted to surrounding themselves with a lifestyle full of fast-food consumptions, alcohol, and smoking. The extreme use of such life-threatening factors has affected the lives of thousands of people in the world.

It is also observed that rise in geriatric population in the developed areas such as U.K and U.S has further led to a rise in the demand for organ transplant procedures. Such regions, health-conditions, and viability from the time of organ donation to transplantation aspects have essentially propelled the growth of this particular market segment.

Supplementary – Growth Contributors

The rise in per capita healthcare expense and the advancing imbursement arrangements for the organ transplant procedures in different nations such as U.S, U.K, and India are auxiliary factors that have helped in the overall growth of the organ preservation solutions market. This would enable the patients to afford the medical procedures and reduce their medical expenses, as well as provide better healthcare services.

In addition, the growth of this market will also be driven with the emergence of technologically improved products such as Lifor. Lifor is termed as a blood surrogate that will clinically prove its effectiveness in saving and preserving human and veterinary organs with utmost safety.

The global market for organ preservation solutions has been predicted to grow at a CAGR rate of 16.5% during the forecast period 2013 to 2019, with a prediction for the market revenue to reach USD 204.9 million in the same forecast period. The geographically active regions that help in the growth of the organ preservation solutions market include Europe (49.96%), North America (42.23%), Asia-Pacific (5.66%), and RoW (2.15%) for 2012 (%).

Nanomedicine Market: An Overview of Growth Factors and Future Prospects

Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.

Nanomedicine is based on the utilization of knowledge pertaining to various nanoparticles, their medical usages, and their actions within the human body.

There still exists considerable scope for research in this domain, and scientists are currently engaged in further studying the treatment-worthiness of a number of nanoparticles such as fullerenes, dendrimers, drug conjugates, and nano crystals.
It is important to note that this area of medicine is still in its nascent stage mainly because it is a niche research area and it receives comparatively less research funding.

Future prospects of the nanomedicine market

A research report by Transparency Market Research, a U.S.-based market research company, projects that the nanomedicine market will be largely driven by partnerships between global research firms and leading industry institutes. These collaborations will play a crucial part in attracting more investments. The report states that the global market for nanomedicine is projected to witness a compounded annual growth rate (CAGR) of 12.3% between 2013 and 2019.

Oncology – a significant segment within the nanomedicine market

According to the market research report by Transparency Market Research, oncology was the largest application segment within the nanomedicine market with a total share of 38%. This is attributed to the large scale focus on developing drugs and treatments for cancer, and the fact that approved nanomedicine drugs also exist in the market.

However, cardiovascular applications of nanomedicine are regarded as being the fastest-growing segment within the nanomedicine market. A large number of people being affected by cardiovascular problems worldwide, and the availability of various devices catering to the needs of this patient segment are growth influencers in this market.

In addition, there has been a perceptible increase in support from various governments in bolstering research as well as product approvals within the nanomedicine segment; with this support likely to continue, the market for nanomedicine will continue to grow.

The need for research, investment and collaboration in the nanomedicine market

In the coming years, it is expected that further collaborations between academic institutes as well as research firms will provided a much-needed boost to the role of nanomedicine in chronic disease treatment.

Research and breakthroughs could lead to the emergence of new treatments and technologies, with more bioavailability.
Other factors such as a growing demand and acceptance of targeted drug delivery (especially where neurological disorders are concerned) has created a larger market for nanomedicine.

On the other hand, the prevalence of cardiovascular diseases is on the rise, and this trend asks for the introduction of drugs that possess higher efficiency and better therapeutic properties. This is yet another need that will propel demand for nanomedicine products.

Nanomedicine has already met with some success in oncology, and researchers and market players alike are buoyed by this success. Having realized the efficacy of nanomedicine in oncology, it is likely that the interest shown by market players to commercialize products in this segment will only rise.

It is projected that cardiovascular treatments are likely to emerge as the fastest growing market within the nanomedicine market between 2013 and 2019.

Increased collaboration between academic and research institutes will prove favorable for the nanomedicine market. A noteworthy example of this would be the collaboration between Elan Corporation Plc and Abbott Laboratories for the development of the Tricor drug. This collaboration was key to helping both players lower cost associated with research and development.

Looking forward, market analysts expect that breakthroughs in nanomedicine will be crucial to the development of treatments and products for diseases such as diabetes, cancer, neurological disorders, and cardiovascular diseases.

Sports Medicine Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Sports Medicine Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Sports Medicine Devices Market Expected to Reach USD 8.3 Billion Globally in 2019: Transparency Market Research

Sports Medicine Devices Market 2

Transparency Market Research is Published new Market Report “Sports Medicine Devices Market (Artificial Joint Implants, Arthroscopy Devices, Fracture Repair Devices, Prosthesis, Orthobiologics, Braces, Performance Monitoring Devices, Accessories, Other Recovery Products) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” the global sports medicine devices market was valued at USD 6.1billion in 2012 and is expected to grow at a CAGR of 4.4% from 2013 to 2019, to reach an estimated value of USD 8.3 billion in 2019.

Browse Global Sports Medicine Devices Market Report with Full TOC at http://www.transparencymarketresearch.com/sports-medicine-device-market.html

Sports medicine refers to a branch of medical field involving physical fitness, treatment and prevention of sports and exercise related injuries. A growing population across the globe is creating a larger pool of talent exploited by better health, nutrition, and coaching leading to thesurge in new medical device innovation in the sporting arena. New treatments aimed at preserving joint structures may protect young athletes from more invasive procedures. Alarge pool ofelderly population and their rising awareness for health and fitness, in order to control disorders like diabetes and obesity,contribute to the rise in number of injuries. This eventually will lead to growth of the marketglobally.The reimbursement scenario however is posing a challenge to the market growth. Most of the medial insurances do not cover sports injuries at school and college level and have other clauses which exclude out of state treatment. Rising cost of medical treatment and uncovered sports injuries have affected the parents support to sports activities among children in school.

The global market for sports medicine deviceshas been studied from the perspective of widely used orthopedic devices and number of procedures used to treat and recover from sports injuries.The report provides a detailed analysis of orthopedic products such as artificial joint implants, arthroscopy devices, fracture repair devices, prosthesis and orthobiologics. Detailed analysis for recovery and support products has also been included in the report. These products comprises braces, performance monitoring devices, accessories and other recovery products.The other recovery products segment includes thermotherapy, cryotherapy, ultrasound therapy, electric stimulation devices and compression clothing.

Browse the full report PDF with TOC : Sports Medicine Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

In 2012, arthroscopy devices accounted for the largest share by revenue of the total sports medicine devices market. The global arthroscopy devices market was valued at USD 1.6 billion in 2012 and is expected to grow at a CAGR of 5.8% from 2013 to 2019, to reach an estimated value of USD 2.4 billion in 2019. This market segment is followed by artificial joint implants and fracture repair devicesowing to the rise in demand for joint replacement procedures andhigh incidence rate of fractures. However, the product recalls caused due to factors such as corrosion, implant loosening, wear, and manufacturing errors are expected to have a major impact on the market revenue of these market segments.Braces form a major share of the recovery and support products in sports medicine contributing to around 22% of the total market share in 2012.A wide application of braces coupled with rising cost of rehabilitation has propelled the orthotics market in sports medicine.

In terms of revenue, North America forms the largest market for sports medicine devices with a share of around 40%. It is expected to maintain its position throughout the forecast period propelled byrise in injuries due to variety of sports, coupled with various increasing specialized sports medicine services.According toa research conducted by Safe Kids Worldwide, around 1.3 million children were treated in emergency rooms for sports related injuries in the year 2012 in U.S. alone. Europe forms the second largest market for sports medicine devices, due to the increased demand for treatment and prevention for sports injuries.Europe being the first preference for product launch owing to favorable regulatory agency has an advantage over the more stringent U.S. FDA regulations.

Asia-Pacific is expected to be the fastest growing region in the global sports medicine devices market from 2013 to 2019, owing to the surge in sports injuries, improving healthcare infrastructure, coupled with increasing fitness awareness amongst the youth as well as elderly population. Owing to low cost manufacturing regions and favorable taxation on the devices, these regions have been successful in attracting foreign players to enter this lucrative market. Significant support from the governments of these nations has also led to growth of this sector. This provides leverage for market growth in the Asia-Pacific region.Expansion of medical centers, organizations and hosting of medical conferences to create healthcare awareness is expected to the drive the sports medicine market in the developing regions of Latin America, the Middle East and Africa.

Arthrex, Arthrocare Corporation, Biomet, Smith and Nephew PLC, Zimmer, DepuyMitek, Ottobock, DJO Global and Ossur are some of the key players dominating the global sports medicine devices market. Moreover, a large number of new companies areon constant search for innovative technologies for repair of damaged tendons, meniscus, ligaments,cartilage, and other soft tissue structures in order toenter the sports medicine devices market.

The global sports medicine devices marketis segmented as follows:

Sports Medicine DevicesMarket, by Orthopedic Products

  • Artificial Joint Implants
  • Arthroscopy Devices
  • Fracture Repair Devices
  • Prosthesis
  • Orthobiologics

Sports Medicine Devices Market, by Recovery and Support Products

  • Braces
  • Performance Monitoring Devices
  • Accessories
  • Other Recovery Products
    • Thermotherapy
    • Cryotherapy
    • Ultrasound
    • Electric Stimulation Devices
    • Compression Clothing

Sports Medicine Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

 

About US :

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Browse all   Technology & Media Research Reports @ http://www.transparencymarketresearch.com/technology-market-reports-8.html

Contact us :

Sheela AK

90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/

Operating Room Equipment Market Will Reach USD 4.05 Billion in 2019

Operating Room Equipment Market Will Reach USD 4.05 Billion in 2019

Operating Room Lights, Surgical Booms, Operating Room Integration Systems and Surgical Imaging Displays) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

An operating room (OR) is a facility within a hospital or a clinic where various surgeries are performed on patients in order to treat different physiological and pathological conditions. Technological advancements have brought a lot of change in the way surgical procedures are carried out today. Operating rooms are becoming more spacious with new and advanced operating tables, operating room lights, high resolution and high definitionsurgical imaging displays, that have become an indispensable part of modern hybrid operating rooms.

The market for operating room equipment can be broadly segmented into operating tables, OR lights, surgical booms, OR integration systems and surgical imaging displays. The operating tables market has been further segmented into general operating tables and specialty operating tables. In 2012, the operating tables segment held the largest share (30.6%) of the total market, followed by operating room lights. During the forecast period 2013 to 2019, the demand for general operating tables is expected to be stagnant or very slow and the overall growth will be offset by the increasing demand of specialty surgery tables. The OR integration systems market has been predicted as the fastest growing segment during the forecast period.

Browse the report With Full TOC :  http://www.transparencymarketresearch.com/operating-room-equipment.html

Some of the major factors expected to drive growth of the OR equipment market during the forecast period include increasing number of ambulatory surgical centers (ASCs) across the globe, rising demand for a wide range of modern operating room equipment and growing trend for adopting hybrid operating rooms. According to the U.S. Medicare Payment Advisory Commission (MedPAC), during 2006 to 2010, the number of Medicare-certified ASCs increased by an average annual rate of 3.6% in the country, and this continuous increase in the number of ASCs is likely to contribute to the increasing demand for various operating room equipment. Hybrid ORs are an advanced form of operation theatres that involve integration of surgical function with imaging modalities and ensure enhanced operational efficiency. Hybrid operating rooms offer surgeons and other healthcare professionals greater operational flexibility by enabling easy access to various surgical as well as imaging equipment such as CT and MRI scanners.

North America held the largest share in the global operating room equipment market in terms of revenue in 2012. One of the key factors responsible for this region to hold leadership position is the presence of major players in the U.S. that consider North American market as their primary market for revenue generation and thus many technological advancements are first introduced in this market. Europe held the second largest market in 2012, followed by Asia-Pacific. In Asia-Pacific, the market is expected to grow under the influence of factors such as the exponentially rising medical tourism industry, continuously improving healthcare infrastructure and increasing penetration by U.S. and Europe-based equipment manufacturers.

Getinge Group, Stryker Corporation, Steris Corporation, TRUMPF GmbH + Co. KG, Berchtold Corporation, Skytron, LLC, Karl Storz GmbH & Co. KG, Eschmann Equipment, Mizuho OSI and NDS Surgical Imaging, LLC are the major companies engaged in the development, manufacturing and commercialization of various operating room equipment. These players are in constant competition with each other in order to gain a competitive edge over others. These manufacturers supply their operating room equipment to small, mid and large-sized hospitals.

Operating Room Equipment Market, by Product Type

  • Operating Tables
  • Operating Room Lights
  • Surgical Booms
  • Operating Room Integration Systems
  • Surgical Imaging Displays

Operating Room Equipment Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Related & Recently Published Reports by Transparency Market Research

Orthopedic Devices Market (Hip, Knee, Spine, Shoulder, Elbow, Foot and Ankle, Craniomaxillofacial and Other Extremities) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Orthopedic devices are used to restore skeletal structure and joint movements in various types of fractures, abnormal growth of bones, soft tissue damage, trauma or other deformities. These devices can be surgically implanted or externally attached through minimally invasive procedures and hence can be classified as joint implants, internal and external fixation devices. Demand for orthopedic procedures is expected to grow in the near future owing to the increase in geriatric population and obesity across the globe.

The major orthopedic device segments such as joint implants, internal and external fixation devices have been further analyzed on the basis of anatomical locations namely, hip, knee, shoulder, elbow, foot and ankle and other extremities. Spinal orthopedic devices have been segmented into joint implants and internal fixation devices, while craniomaxillo facial devices market include estimations only for internal fixation devices. Various emerging technologies such as bio-absorbable implants and minimal invasive procedures currently form major drivers for the growth of this market. The global orthopedic devices market was valued at USD 29.2 billion in 2012 and is expected to grow at a CAGR of 4.9% from 2013 to 2019, to reach an estimated value of USD 41.2 billion in 2019.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html